REXFOCAS
Vertex Pharmaceuticals Incorporated
Mark For: REXFOCAS™ trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97096667 |
| Mark Literal Elements | REXFOCAS |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark |
| Current Location | INTENT TO USE SECTION 2022-11-15 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Timothy H. Hiebert |
Timeline
| 2021-10-28 | Application Filed |
| 2021-11-01 | Location: NEW APPLICATION PROCESSING |
| 2021-11-01 | Status: Live/Pending |
| 2021-11-01 | Transaction Date |
| 2022-09-20 | Published |
| 2022-11-15 | Location: INTENT TO USE SECTION |
| 2023-11-13 | Status: A second request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Vertex Pharmaceuticals Incorporated |
| Address | 50 Northern Avenue Boston, MASSACHUSETTS UNITED STATES 02210 |
| Legal Entity Type | Corporation |
| Legal Entity State | MASSACHUSETTS |
Documents
 Drawing | 2021-10-28 | |
| TEAS Plus New Application | 2021-10-28 | |
| Preliminary Amendment | 2022-04-10 | |
| Amendment and Mail Process Complete | 2022-04-12 | |
| Public Note | 2022-08-09 | |
| XSearch Search Summary | 2022-08-09 | |
| TRAM Snapshot of App at Pub for Oppostn | 2022-08-16 | |
| Notice of Publication | 2022-08-31 | |
| Notification Of Notice of Publication | 2022-08-31 | |
| OG Publication Confirmation | 2022-09-20 | |
| Notice of Allowance | 2022-11-15 | |
| Change Address or Representation Form | 2022-11-30 | |
| Extension of Time to File SOU | 2023-05-01 | |
| ITU Extension Approval | 2023-05-03 | |
| ITU Unit Action | 2023-05-03 | |
| Extension of Time to File SOU | 2023-11-13 | |
| ITU Extension Approval | 2023-11-15 | |
| ITU Unit Action | 2023-11-15 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of thalassemia and sickle cell disease |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-11-15 | |
| SOU TEAS EXTENSION RECEIVED | 2023-11-13 | |
| SOU EXTENSION 2 GRANTED | 2023-11-13 | |
| SOU EXTENSION 2 FILED | 2023-11-13 | |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-05-03 | |
| SOU TEAS EXTENSION RECEIVED | 2023-05-01 | |
| SOU EXTENSION 1 GRANTED | 2023-05-01 | |
| SOU EXTENSION 1 FILED | 2023-05-01 | |
| TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | 2022-11-30 | |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-11-30 | |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-11-30 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-11-30 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-11-15 | |
| PUBLISHED FOR OPPOSITION | 2022-09-20 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-09-20 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-08-31 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-08-15 | |
| ASSIGNED TO EXAMINER | 2022-08-08 | |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2022-04-10 | |
| TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | 2022-04-10 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2021-11-09 | |
| NEW APPLICATION ENTERED IN TRAM | 2021-11-01 | |
| NEW APPLICATION ENTERED | 2021-11-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 